CI Company Profile and Key Details

Q: Who are the executives of CI?

Mr. Eric Paul PalmerPres & Chief Executive Officer of EvernorthMr. Paul SanfordExecutive Vice President of OperationsMs. Mary Terese Agoglia Hoeltzel CPASenior Vice President of Tax & Chief Accounting OfficerMr. David Michael CordaniPres, Chief Executive Officer & Chair of the BoardMs. Noelle K. EderExecutive Vice President & Global Chief Information OfficerMs. Cynthia RyanExecutive Vice President & Chief HR OfficerMr. Ralph GiacobbeSenior Vice President & Head of Investor RelationsMr. Brian C. EvankoExecutive Vice President & Chief Financial OfficerMr. Everett NevilleExecutive Vice President of Strategy, Corporation Devel. & SolutionsMs. Nicole Susan JonesExecutive Vice President & Gen. Counsel

NYSE : CI

Cigna

$284.53

12.82+4.72%

At Close 4:00 PM

63.43

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Cigna Corporation (CI) stock surged +4.72%, trading at $284.53 on NYSE, up from the previous close of $271.71. The stock opened at $277.20, fluctuating between $273.95 and $284.66 in the recent session.

Stock Snapshot

271.71

Prev. Close

76.01B

Market Cap

273.95

Day Low

12.04

P/E Ratio

23.64

EPS (TTM)

35.01

Cash Flow per Share

277.2

Open

267.13M

Number of Shares

284.66

Day High

99.52%

Free Float in %

158.03

Book Value

3.92M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 05, 2026	277.20	285.00	273.95	284.53	3.92M
Feb 04, 2026	269.80	281.87	269.16	271.71	4.08M
Feb 03, 2026	271.76	276.71	271.33	275.39	1.37M
Feb 02, 2026	272.09	275.84	268.76	271.54	1.89M
Jan 30, 2026	271.51	274.11	268.45	274.11	1.75M
Jan 29, 2026	273.52	276.09	270.17	271.27	1.55M
Jan 28, 2026	268.90	273.58	265.75	272.38	1.58M
Jan 27, 2026	279.00	281.39	269.58	270.09	2.22M
Jan 26, 2026	279.50	281.49	277.10	280.41	1.31M
Jan 23, 2026	279.99	281.01	277.79	279.20	1.02M
Jan 22, 2026	274.75	280.73	274.26	280.39	1.37M
Jan 21, 2026	271.54	276.43	270.62	274.91	1.18M
Jan 20, 2026	270.57	274.48	268.36	271.24	1.48M
Jan 16, 2026	276.32	276.96	270.77	272.21	1.63M
Jan 15, 2026	271.54	278.00	268.95	277.94	1.66M
Jan 14, 2026	272.19	276.67	270.96	271.00	1.82M
Jan 13, 2026	276.49	276.50	270.31	271.81	1.01M
Jan 12, 2026	279.50	279.50	270.56	276.02	1.54M
Jan 09, 2026	286.53	286.88	278.20	278.95	1.67M
Jan 08, 2026	280.31	286.73	279.51	283.91	1.4M

Contact Details

Bloomfield, CT 06002

United States

https://www.cigna.com 860 226 6000

About Company

The Cigna Group provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Stock Peers

ELV

-8.35-2.45%

Elevance Health Inc.$332.25 UNH

-7.37-2.67%

UnitedHealth Group Incorporated$268.55 HUM

1.48+0.77%

Humana Inc.$193.55 MOH

-1.23-0.69%

Molina Healthcare, Inc.$176.81 CVS

1.09+1.45%

CVS Health Corporation$76.33 CNC

-1.04-2.54%

Centene Corporation$39.92 BHG

1.4+9.36%

Bright Health Group, Inc.$16.35 OSCR

-0.71-5.37%

Oscar Health, Inc.$12.51

Company Overview

Cigna Corporation (NYSE:CI) closed at $284.53 USD, gaining $12.82 (4.72%) from the previous close of $271.71. The stock is currently mid-range between its 52-week high and low $239.51 and $350.00. With a market capitalization of about $76.01 billion, Cigna Corporation is classified as a large-cap and shows lower-than-market volatility (beta ~0.28). Key stats such as the average daily volume over the past year has been around 1.74 million shares, trading with heavier-than-usual volume. Headquartered in Bloomfield, CT, Cigna Corporation operates in the Healthcare sector and the Medical - Healthcare Plans industry. Led by CEO David Michael Cordani, the company employs approximately 71,295 people and listed since March 31, 1982. The Cigna Group provides insurance and related products and services in the United States.

Technical Performance

CI has shown mixed momentum, losing -1.73% over the past week and -9.37% over the past quarter, though year-to-date performance is down -1.45%. Short-term trend indicators are mixed aligned (SMA20 3.3%, SMA50 3.61%, SMA200 -3.43%). The stock’s 14-day RSI is 58.64 (neutral), while the ATR of 7.33 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -18.71% below its high and over 18.8% above its low. Average 10-day trading volume of 2.30 million shares is slightly above the 3-month average of 1.75 million, indicating heightened recent market interest.

Valuation Metrics

Cigna Corporation trades at a P/E ratio of 12.64, slightly below the S&P 500 average, with a price-to-sales ratio of 0.28 and a price-to-book ratio of 1.8 suggesting the stock is closer to book value. The P/FCF stands at 10.18, also above market averages.

Dividend & Fair Value

Cigna Corporation last paid a dividend of 6.04 per share, this equals a trailing yield of roughly 1.44%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $913.15. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Cigna Corporation generated EPS of $22.67 over the past year. Five-year average earnings growth is -2.04%. Wall Street analysts project EPS growth of 6.99% annually over the next five years. The latest quarter delivered EPS of $7.83. The next quarter is forecast at $7.88. Next year's EPS is expected at $13.74. Analyst sentiment is bullish. Analyst rating data shows there are 10 Strong Buy ratings, 7 Buy ratings, 4 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $384.00 to $294.00. The high target offers 34.96% upside. The low target suggests 3.33% downside. The mean target is $345.52. This offers 21.44% upside. Cigna Corporation earnings surprise history is a consistent trend of beating forecasts. The quarter that ended October 30, 2025, missed forecasts by 2.49%. The prior quarter beat by 0.56%. Over the last six quarters, Apple has recorded several small beats. These include 4.51% in August 01, 2024.

Shareholding & Insider Activity

Cigna Corporation has 266.93 million shares outstanding. The public float is 265.64 million shares, elevated short interest at 1.65% of float. This equals 3.32 million shares. The short ratio is 1.61 days. Institutional investors hold 91.6% of the float. Insiders own 1.59%. Cordani David holds 157.94 thousand shares, Evanko Brian C has 51.18 thousand shares and Palmer Eric P has 44.65 thousand shares. Over the past six months, insider transactions show net selling. They sold 33.89 thousand shares across 2 transactions.

Financial & Profitability Overview

Over the trailing twelve months, Cigna generated $195.19B in revenue, or $657.46 per share. Gross margin was 81.41%, operating margin 2.65%, and net profit margin 2.65%. Returns are modest, with ROA at 3.49% and ROE at 11.17%.
On valuation metrics, Cigna trades at a P/E of 12.64, P/S of 0.28 and P/B of 1.80. Liquidity is tight, with a current ratio of 0.83 and quick ratio of 0.73. Operationally, the company’s inventory turnover is 32.32 and cash conversion cycle is -26.11 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is 0.81, supported by a cash flow-to-debt ratio of 0.25.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Cigna posted revenue of $195.19B, down slightly from $180.64B in the prior quarter. Gross profit was $158.90B (margin 81.41%). Operating income was $5.16B (margin 2.6%). Net income was$5.16B (EPS $17.57).
The company ended the quarter with $8.75B in cash and short-term investments, a total debt of $31.48B, and net debt of $23.66B. Total assets were $147.93B, with equity of $46.35B. Financials further reflected stability, with operating cash flow of $11.81B, free cash flow of $10.24B, and capital expenditures of - $1.57B.

Price Forecast & Outlook

Our AI price prediction model suggests that Cigna Corporation stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -2.11%, with price expected at $278.52 by February 19, 2026, within a range of $274.58 to $282.61 3-Month Outlook: Projected rise of 69.88%, reaching $483.37 by May 06, 2026, with a range of $467.21 to $501.54. 1-Year Outlook: Projected loss of -0.65%, with price at $282.69 by February 05, 2027, within a range of $270.38 to $292.49.

Key Takeaways

Cigna Corporation (NYSE:CI) shares are flat -1.45% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Cigna Corporation trading at a premium to the broader market with a P/E of 12.64. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $343.20, suggesting 20.62% upside. Our AI forecast model points to short-term weakness (-2.11% over two weeks), a medium-term rise (69.88% over three months), and a longer-term loss (-0.65% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Cigna Corporation (CI) stock price?

Cigna Corporation (NYSE: CI) stock price is $284.53 in the last trading session. During the trading session, CI stock reached the peak price of $284.66 while $273.95 was the lowest point it dropped to. The percentage change in CI stock occurred in the recent session was 4.72% while the dollar amount for the price change in CI stock was $12.82.

CI's industry and sector of operation?

The NYSE listed CI is part of Medical - Healthcare Plans industry that operates in the broader Healthcare sector. Cigna Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of CI?

Mr. Eric Paul Palmer
Pres & Chief Executive Officer of Evernorth
Mr. Paul Sanford
Executive Vice President of Operations
Ms. Mary Terese Agoglia Hoeltzel CPA
Senior Vice President of Tax & Chief Accounting Officer
Mr. David Michael Cordani
Pres, Chief Executive Officer & Chair of the Board
Ms. Noelle K. Eder
Executive Vice President & Global Chief Information Officer
Ms. Cynthia Ryan
Executive Vice President & Chief HR Officer
Mr. Ralph Giacobbe
Senior Vice President & Head of Investor Relations
Mr. Brian C. Evanko
Executive Vice President & Chief Financial Officer
Mr. Everett Neville
Executive Vice President of Strategy, Corporation Devel. & Solutions
Ms. Nicole Susan Jones
Executive Vice President & Gen. Counsel

How CI did perform over past 52-week?

CI's closing price is 18.8% higher than its 52-week low of $239.51 where as its distance from 52-week high of $350.00 is -18.71%.

How many employees does CI have?

Number of CI employees currently stands at 71,295.

Link for CI official website?

Official Website of CI is: https://www.cigna.com

How do I contact CI?

CI could be contacted at phone 860 226 6000 and can also be accessed through its website. CI operates from 900 Cottage Grove Road, Bloomfield, CT 06002, United States.

How many shares of CI are traded daily?

CI stock volume for the day was 3.92M shares. The average number of CI shares traded daily for last 3 months was 1.74M.

What is the market cap of CI currently?

The market value of CI currently stands at $76.01B with its latest stock price at $284.53 and 267.13M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	71295
Beta	0.27
Sales or Revenue	$195.19B
5Y Sales Change%	2.373%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Healthcare Plans

CI Company Profile and Key Details

Cigna

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Company Overview

Dividend & Fair Value

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Earnings & Analyst Outlook

Price Forecast & Outlook

Key Takeaways